31

32
Eiji Kosaka, Shigeru Murakami: Photosensitive resin composition and photosensitive element using the resin composition. Nichigo Morton, Christine C O&apos Day, Edwards & Angell, June 5, 2001: US06242158 (2 worldwide citation)

To provide a photosensitive resin composition and a photosensitive element using the resin composition with excellent sensitivity and adhesion as well as high resolution and plating resistance. A photosensitive resin composition, comprises (A) a polymer carrying carboxyl groups, (B) a compound carry ...


33
Shien Chang Chen, Fu Shen Lin, June Yen Chou, Liang An Hsu, Ming Hui Chu, Chine Chung Huang, Ming Hsiung Shao: Method for preparing polyether polyol and copolymer thereof. Dairen Chemical Corporation, Peter F Corless, Christine C O&apos Day, Edwards & Angell, November 6, 2001: US06313262 (2 worldwide citation)

The present invention is related to a method for preparing polyether polyol or copolymerized polyether polyol, which uses an acid catalyst consisting of heteropoly acidic salts and oxides and/or binders. It allows tetrahydrofuran and/or cyclic ether compounds to carry out the ring-opening polymeriza ...


34

35
Kil Do Cho, Dong Yeun Kim, Dong Woo Park, Hong Ryeol Jeon, Hee Jun Kim: Optimally stabilized microgranule comprising 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative. IL Yang Pharm, Peter F Corless, Christine C O&apos Day, Dike Bronstein Roberts and Cushman Intellectual Property Practice Group, August 28, 2001: US06280773 (2 worldwide citation)

The present invention relates to a microgranule prepared by using an alkali compound as a stabilizer for a 5-pyrrolyl-2-pyridylmethylsulfinylbenzimidazole derivative having the following formula (1), which is a very effective antiulcerative but highly unstable under acidic conditions, and by using a ...


36
Wieslaw M Cholody, Teresa Kosakowska Cholody, Christopher J Michejda: 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity. The United States of America represented by the Department of Health and Human Services, Peter F Corless, Christine C O&apos Day, Edwards & Angell, December 16, 2003: US06664263 (2 worldwide citation)

The invention provides imidazoacridone compounds of general formula (1) which have cytotoxic and anti-tumor activity. The invention also provides methods of preparing the compounds, and methods of using the compounds for the treatment of cancer or other mammalian diseases characterized by undesirabl ...


37
Hiroshi Sugiyama, Zhi Fu Tao, Isao Saito: Compounds capable of cleaving double-stranded DNA and method of utilization of the same. Japan Science and Technology Corporation, Peter F Corless, Christine C O&apos Day, Edwards & Angell, March 30, 2004: US06713633 (2 worldwide citation)

Novel chemical species capable of simultaneously alkylating double-stranded DNA and cleaving the same; methods for alkylating and cleaving DNA by using these species; and anticancer agents with the use of these compounds. Compounds represented by the following general formula (I) which are capable o ...


38
Toyojiro Muramatsu, Katsumi Mashita, Yasuo Shinoda, Hironori Sassa, Hiroyuki Kawashima, Yoshio Tanizawa, Hideatsu Takeuchi: Stable pharmaceutical composition. Kowa Company, Nissan Chemical, Peter F Corless, Christine C O&apos Day, Edwards & Angell, October 15, 2002: US06465477 (2 worldwide citation)

Disclosed is a pharmaceutical composition comprising (E)-3,5-dihydroxy-7-[4′-4″-fluorophenyl-2′-cyclopropyl-quinolin-3′-yl]-6-heptenoic acid, or its salt or ester, of which the aqueous solution or dispersion has pH of from 6.8 to 8. The composition has good time-dependent stability and has ...


39

40
Shuji Hinuma, Yugo Habata, Yuji Kawamata, Masaki Hosoya, Ryo Fujii, Shoji Fukusumi, Chieko Kitada: Polypeptides their production and use. Takeda Chemical, David G Conlin, Christine C O&apos Day, Edwards & Angell, May 8, 2001: US06228984 (1 worldwide citation)

The present invention relates to the ligand polypeptide for the human pituitary- and mouse pancreas-derived G protein-coupled receptor proteins. The ligand polypeptide or the DNA which codes for the ligand polypeptide can be used for (1) development of medicines such as pituitary function modulators ...